DBV Tech's Non-Invasive Allergy Tests at BIO 2007
Share:
DBV Technologies has developed a unique globally patented technology, VIASKIN®, for the cutaneous administration of proteins and peptides. The company released the first ready-to-use patch test for diagnosing cow's milk allergy based on this unique technology: Diallertest® Milk. DVB Technologies will exhibit at BIO 2007 in Boston May 6 to 9 at booth 1314 and will present VIASKIN® and its applications at the BIO Business Forum on May 8 at 9:15 a.m. in room A.
VIASKIN®, the 2006 Siemens Prize for Innovation winner, is a dry, disc-shaped cutaneous device system that holds an active ingredient in powder form on an electrically charged plastic film that only delivers it when VIASKIN® is placed on the skin. Application of the disc creates a occlusive chamber between the disc and the skin, making the chamber's conditions humid enough to hydrate and release the active ingredient, and to open the skin's pores to better absorb the active ingredient.
Diallertest® Milk uses this technology to diagnose cow's milk protein allergy and is suitable for everyday medical practice. Practical, simple to use, and painless as it is completely non-invasive, and it can be applied directly by the parents to the child's back at home. It significantly improves the effectiveness in the diagnosis of cow's milk protein allergy. The faster the diagnosis and treatment, the lower the risk of developing allergosis. DVB is also developing Diallertest® to diagnose dust mite, soy, and wheat allergies.
The milk allergy test will soon be available to the United States. DBV Technologies and Numico, a Dutch company specializing in the production and sale of nutritional foodstuffs, have announced a distribution agreement for Diallertest® Milk that will extend its original network to include the entire world. Since February 2006, Nutricia, Numico's French subsidiary, has distributed Diallertest® Milk in France. Today, about 70,000 tests have already been prescribed. The test is available in Australia, France, the Middle East, and New Zealand.
About DBV Technologies:
Founded in 2002, DBV Technologies was created by Pierre-Henri Benhamou, a pediatrician specializing in gastro-enterology, allergosis, and nutrition, and Bertrand Dupont, a qualified engineer from the Arts et Metiers institute. Today it is chaired by Jean-Francois Biry, CEO. The company has perfected and globally patented the VIASKIN® technology. VIASKIN® is a unique delivery system that retains the active principle on the carrier using electrostatic forces only. One of the initial applications of this patch is the diagnosis and treatment of allergies. Diallertest, the first product sold to date, is designed specifically for the diagnosis of cow's milk protein allergy, which occurs very frequently in infants. This product represents a real revolution for pediatrics and was awarded International Prize for Technological Innovation by the Altran foundation. VIASKIN® technology won the Siemens Prize for Innovation 2006.
For more information, please contact:
DBV TECHNOLOGIES
Jean-Francois Biry
CEO
E-mail: jfbiry@dbv-technologies.com
Nathalie Donne
Project Manager
88, avenue General Leclerc
92100 BOULOGNE BILLANCOURT
France
Tel: +33 (0)1 55 38 92 70
Fax: +33 (0)1 41 31 28 82
Mobile: +33 (0)6 67 67 44 97
E-mail: nathalie.donne@dbv-technologies.com
Web: dbv-technologies.com/en/home-corp.htm
